bromodeoxyuridine has been researched along with Chagas Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, JB; Araujo, MS; Napimoga, MH; Silva, GA | 1 |
| Albanese, C; Bouzahzah, B; Christ, GJ; de Almeida, CJ; Desruisseaux, MS; Hassan, GS; Huang, H; Lisanti, MP; Mukherjee, S; Nagajyothi, F; Pestell, RG; Petkova, SB; Tanowitz, HB; Weiss, LM | 1 |
| Bixby, LM; Bustamante, JM; Tarleton, RL | 1 |
3 other study(ies) available for bromodeoxyuridine and Chagas Disease
| Article | Year |
|---|---|
Delay in maturation of the submandibular gland in Chagas disease correlates with lower DNA synthesis.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Chagas Disease; DNA; Fas Ligand Protein; Immunohistochemistry; Male; Proto-Oncogene Proteins c-bcl-2; Rats; Submandibular Gland; Time Factors | 2008 |
Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.
Topics: Animals; Bromodeoxyuridine; Carotid Arteries; Caveolins; Cell Cycle; Cell Proliferation; Cells, Cultured; Chagas Disease; Cyclin D1; Endothelial Cells; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Mice; Mice, Inbred A; Mice, Inbred C3H; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Receptor, Endothelin A; RNA Precursors; Trypanosoma cruzi | 2006 |
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.
Topics: Animals; Bromodeoxyuridine; CD8-Positive T-Lymphocytes; Chagas Disease; Immunologic Memory; Immunophenotyping; Mice; Nitroimidazoles; Receptors, Chemokine; Treatment Outcome; Trypanosoma cruzi | 2008 |